Abstract |
We previously observed that rhinacanthins, which are the main naphthoquinone esters isolated from the roots of a Thai medicinal plant, Rhinacanthus nasutus KURZ. (family Acanthaceae), suppress the growth of Meth-A sarcoma in the tumor-bearing mice and that rhinacanthin-N has the strongest antitumor activity among these naphthoquinone esters tested. In the present study, we investigated the effect of rhinacanthin-N on pulmonary metastasis induced by B16F10 melanoma cells in mice. C57BL/6 male mice were injected intravenously with B16F10 melanoma cells, and liposomal rhinacanthin-N was administered intraperitoneally from day 1 to 7 after tumor implantation. Liposomes were used to formulate an injectable form of the hydrophobic agent. Treatment of the mice with 5 or 10 mg/kg/d of liposomal rhinacanthin-N significantly inhibited the pulmonary metastatic colonization of the melanoma cells. Based on these data, our findings demonstrate that rhinacanthin-N possesses antimetastatic efficacy, which may make it a lead compound for the development of a new anticancer drug for use in cancer chemotherapy.
|
Authors | Pongpun Siripong, Jantana Yahuafai, Suratsawadee Piyaviriyakul, Kwanjai Kanokmedhakul, Hiroyuki Koide, Takayuki Ishii, Kosuke Shimizu, Somsak Ruchirawat, Naoto Oku |
Journal | Biological & pharmaceutical bulletin
(Biol Pharm Bull)
Vol. 35
Issue 7
Pg. 1197-200
( 2012)
ISSN: 1347-5215 [Electronic] Japan |
PMID | 22791173
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Liposomes
- Naphthoquinones
- rhinacanthin-N
|
Topics |
- Acanthaceae
- Animals
- Antineoplastic Agents
(administration & dosage)
- Cell Proliferation
(drug effects)
- Liposomes
- Lung Neoplasms
(drug therapy, secondary)
- Male
- Melanoma, Experimental
(drug therapy, pathology)
- Mice
- Mice, Inbred C57BL
- Naphthoquinones
(administration & dosage)
- Plant Roots
|